GENINUS Inc. (KOSDAQ:389030)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,325.00
+235.00 (11.24%)
At close: Dec 5, 2025

GENINUS Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
Revenue
8,8096,4556,96710,083
Revenue Growth (YoY)
31.38%-7.34%-30.90%-
Cost of Revenue
8,6666,4066,9039,249
Gross Profit
142.9449.8164.63834.02
Selling, General & Admin
6,7828,4146,5864,659
Research & Development
3,0322,1942,2035,327
Amortization of Goodwill & Intangibles
159.26157.27157142.92
Other Operating Expenses
205.8216.09190.9274.11
Operating Expenses
12,44612,30910,14310,510
Operating Income
-12,303-12,260-10,079-9,676
Interest Expense
-437.68-154.36-47.08-8.34
Interest & Investment Income
295.01394.92449.01133.07
Currency Exchange Gain (Loss)
-2.02-8.45-23.290.09
Other Non Operating Income (Expenses)
-322.8-195.7577.7315.28
EBT Excluding Unusual Items
-12,771-12,223-9,622-9,536
Gain (Loss) on Sale of Investments
---166.91
Gain (Loss) on Sale of Assets
-25.66-20.49-44.49-9.06
Asset Writedown
-0-29.64-17.49-6.88
Pretax Income
-12,797-12,273-9,684-9,385
Net Income
-12,797-12,273-9,684-9,385
Net Income to Common
-12,797-12,273-9,684-9,385
Shares Outstanding (Basic)
33333333
Shares Outstanding (Diluted)
33333333
Shares Change (YoY)
0.38%1.17%1.03%-
EPS (Basic)
-383.20-368.25-293.98-287.81
EPS (Diluted)
-383.20-368.25-294.00-287.81
Free Cash Flow
-9,681-13,752-11,300-13,846
Free Cash Flow Per Share
-289.89-412.62-343.01-424.63
Gross Margin
1.62%0.77%0.93%8.27%
Operating Margin
-139.66%-189.91%-144.66%-95.96%
Profit Margin
-145.26%-190.12%-139.00%-93.07%
Free Cash Flow Margin
-109.89%-213.03%-162.18%-137.32%
EBITDA
-8,961-9,548-7,969-8,078
EBITDA Margin
-101.72%-147.90%-114.37%-80.11%
D&A For EBITDA
3,3422,7122,1101,598
EBIT
-12,303-12,260-10,079-9,676
EBIT Margin
-139.66%-189.91%-144.66%-95.96%
Advertising Expenses
-137.21180.24365.23
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.